Pseudomyxoma peritonei: An uncommon tumor

Indian Journal of Medical and Paediatric Oncology

Volumn 31, Issue 2, 2010, Pages 58-61

  Gupta, Surabhi ^a   Singh, Garima ^a   Gupta, Anurag ^a   Singh, Hari ^a   Arya, A ^a   Shrotriya, Deepak ^a   Kumar, Anuj ^a  

^a S N MEDICAL COLLEGE   (India)

Author keywords

Oral capecitabine; Pseudomyxoma peritonei

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADENOCARCINOMA; ADULT; APPENDECTOMY; ARTICLE; ASPIRATION CYTOLOGY; BLEEDING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HERNIORRHAPHY; HUMAN; HUMAN TISSUE; INCISIONAL HERNIA; MUCINOUS ADENOCARCINOMA; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVARY CYST; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

EID: 78650739126     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.71657     Document Type: Article

References (9)

1. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" . Am J Surg Pathol 1995;19:1390-408.
2. Van Ruth S, Acherman YI, van de Vijver MJ, Hart AA, Verwaal VJ, Zoetmulder FA. Pseudomyxoma peritonei: A review of 62 cases. Eur J Surg Oncol 2003;29:682-8.
3. Van Ruth S, Hart AA, Bonfrer JM, Verwaal VJ, Zoetmulder FA.Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2002;9:961-7.
4. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001;27:239-43.
5. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458-63.
6. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004;11:393-8.
7. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:85-91.
8. Levitz JS, Sugarbaker PH, Lichtman SM, Brun EA. Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: Response to capecitabine. J Clin Oncol 2004;22:1518-20.
9. Van Cutsem E, Peeters M. Developments in fluoropyrimidine therapy for gastrointestinal cancer. Curr Opin Oncol 1999;11:312-7.